Insights

Expanding Market Presence Clinipace Worldwide has grown through strategic mergers, notably with Choice Pharma and Accovion, enhancing its global footprint and therapeutic expertise, creating opportunities to offer expanded regulatory and clinical development services.

Stable Financial Position With a funding pool of 26 million dollars and revenue estimates between 10 and 25 million dollars, the company presents a solid financial base that supports expansion and investment in innovative technology solutions for clinical trials.

Innovative Technology Use Powered by the proprietary TEMPO™ eClinical platform and equipped with modern tech stack elements like Google Analytics and Fastly, Clinipace demonstrates a commitment to digital transformation, which can be leveraged to deliver advanced data-driven clinical research services.

Therapeutic Expertise With extensive knowledge across multiple therapeutic areas including oncology, immunology, and infectious diseases, Clinipace is well-positioned to target biotech and biopharma companies looking for specialized clinical trial management and strategic regulatory support.

Highly Skilled Workforce Employing between 501 and 1000 professionals with diverse regulatory, strategic, and operational expertise, Clinipace offers a considerable human resource pool ideal for partnering on large-scale international clinical studies and regulatory projects.

Choice Pharma (now Clinipace Worldwide) Tech Stack

Choice Pharma (now Clinipace Worldwide) uses 8 technology products and services including Fastly, WordPress, jQuery, and more. Explore Choice Pharma (now Clinipace Worldwide)'s tech stack below.

  • Fastly
    Content Delivery Network
  • WordPress
    Content Management System
  • jQuery
    Javascript Libraries
  • Flywheel
    Platform As A Service
  • PHP
    Programming Languages
  • Google Tag Manager
    Tag Management
  • ZURB Foundation
    UI Frameworks
  • Google Analytics
    Web Analytics

Media & News

Choice Pharma (now Clinipace Worldwide)'s Email Address Formats

Choice Pharma (now Clinipace Worldwide) uses at least 1 format(s):
Choice Pharma (now Clinipace Worldwide) Email FormatsExamplePercentage
FLast@clinipace.comJDoe@clinipace.com
93%
FirstLast@clinipace.comJohnDoe@clinipace.com
5%
First.Last@clinipace.comJohn.Doe@clinipace.com
1%
FiLast@clinipace.comJoDoe@clinipace.com
1%

Frequently Asked Questions

Where is Choice Pharma (now Clinipace Worldwide)'s headquarters located?

Minus sign iconPlus sign icon
Choice Pharma (now Clinipace Worldwide)'s main headquarters is located at Rm 402, 4/Floor, Tower 2, Lippo Centre Hong Kong, Hong Kong. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Choice Pharma (now Clinipace Worldwide)'s phone number?

Minus sign iconPlus sign icon
You can contact Choice Pharma (now Clinipace Worldwide)'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Choice Pharma (now Clinipace Worldwide)'s official website and social media links?

Minus sign iconPlus sign icon
Choice Pharma (now Clinipace Worldwide)'s official website is clinipace.com and has social profiles on LinkedIn.

How much revenue does Choice Pharma (now Clinipace Worldwide) generate?

Minus sign iconPlus sign icon
As of October 2025, Choice Pharma (now Clinipace Worldwide)'s annual revenue is estimated to be $3M.

What is Choice Pharma (now Clinipace Worldwide)'s SIC code NAICS code?

Minus sign iconPlus sign icon
Choice Pharma (now Clinipace Worldwide)'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Choice Pharma (now Clinipace Worldwide) have currently?

Minus sign iconPlus sign icon
As of October 2025, Choice Pharma (now Clinipace Worldwide) has approximately 501 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Financial Officer: B. O.Chief Medical Officer: S. M.Vice President & Global Controller: G. L.. Explore Choice Pharma (now Clinipace Worldwide)'s employee directory with LeadIQ.

What industry does Choice Pharma (now Clinipace Worldwide) belong to?

Minus sign iconPlus sign icon
Choice Pharma (now Clinipace Worldwide) operates in the Pharmaceutical Manufacturing industry.

What technology does Choice Pharma (now Clinipace Worldwide) use?

Minus sign iconPlus sign icon
Choice Pharma (now Clinipace Worldwide)'s tech stack includes FastlyWordPressjQueryFlywheelPHPGoogle Tag ManagerZURB FoundationGoogle Analytics.

What is Choice Pharma (now Clinipace Worldwide)'s email format?

Minus sign iconPlus sign icon
Choice Pharma (now Clinipace Worldwide)'s email format typically follows the pattern of FLast@clinipace.com. Find more Choice Pharma (now Clinipace Worldwide) email formats with LeadIQ.

How much funding has Choice Pharma (now Clinipace Worldwide) raised to date?

Minus sign iconPlus sign icon
As of October 2025, Choice Pharma (now Clinipace Worldwide) has raised $26M in funding. The last funding round occurred on Oct 29, 2019 for $8M.

Choice Pharma (now Clinipace Worldwide)

Pharmaceutical ManufacturingHong Kong, Hong Kong501-1000 Employees

We pioneered an innovative service model that has transformed drug and medical device development. Powered by TEMPO™, our proprietary eClinical platform, our team of experts bring extensive therapeutic knowledge and insight into assisting life science, biotechnology and medical device firms in developing and executing regulatory strategies, clinical development, and post-approval research to drug and medical device trials. Our therapeutic expertise includes cardiovascular & metabolic diseases, central nervous system, dermatology, gastroenterology, immunology, infectious diseases, nephrology, oncology, respiratory, rheumatology, & vaccines. Clinipace is headquartered in Research Triangle Park, North Carolina with offices across the globe. 6 Things To Know About Clinipace Worldwide: • We merged with Accovion in 2015 • We merged with Choice Pharma in 2014 • We were named to Forbes' 2013 List of America's Most Promising Companies • We’ve been named to Inc. Magazine’s Inc. 500 List for 6 consecutive years • We’re the first digital clinical research organization (dCRO) • The combined company has supported more than 3,000 clinical research studies and more than 300 regulatory and strategic development projects.

Section iconCompany Overview

Headquarters
Rm 402, 4/Floor, Tower 2, Lippo Centre Hong Kong, Hong Kong
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
501-1000

Section iconFunding & Financials

  • $26M

    Choice Pharma (now Clinipace Worldwide) has raised a total of $26M of funding over 4 rounds. Their latest funding round was raised on Oct 29, 2019 in the amount of $8Mas a equity.

  • $10M$25M

    Choice Pharma (now Clinipace Worldwide)'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $26M

    Choice Pharma (now Clinipace Worldwide) has raised a total of $26M of funding over 4 rounds. Their latest funding round was raised on Oct 29, 2019 in the amount of $8Mas a equity.

  • $10M$25M

    Choice Pharma (now Clinipace Worldwide)'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.